Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?
The prevalence and economic burden of obesity and type 2 diabetes is a driving force for the discovery of molecular targets to improve insulin sensitivity and glycemic control. Here, we review several transgenic mouse models that identify promising targets, ranging from proteins involved in the insulin signaling pathway, alterations of genes affecting energy metabolism, and transcriptional metabolic regulators. Despite the diverse endpoints in each model, a common thread that emerges is the necessity for maintenance of energy balance, suggesting pharmacotherapy must target the development of drugs that decrease energy intake, accelerate energy expenditure in a well controlled manner, or augment natural compensatory responses to positive energy balance.
Department of Physiology, East Carolina University, Greenville, NC, USA.
Laura A A
LA
Gilliam
P Darrell
PD
Neufer
D000818:Animals; D004032:Diet; D004195:Disease Models, Animal; D002149:Energy Intake; D004734:Energy Metabolism; D006801:Humans; D008659:Metabolic Diseases / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic